Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 25.10.2021 | EN | Official Journal of the European Union | C 431/36 |

---

Judgment of the General Court of 8 September 2021 — Cara Therapeutics v EUIPO — Gebro Holding (KORSUVA)

(Case T-584/20) [(1)](#ntr1-C_2021431EN.01003601-E0001)

(EU trade mark - Opposition proceedings - Application for the EU word mark KORSUVA - Earlier national word mark AROSUVA - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EU) 2017/1001)

(2021/C 431/43)

Language of the case: English

Parties

Applicant: Cara Therapeutics, Inc. (Wilmington, Delaware, United States) (represented by: J. Day, Solicitor, and by T. de Haan, lawyer)

Defendant: European Union Intellectual Property Office (represented by: J. Ivanauskas and V. Ruzek, acting as Agents)

Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Gebro Holding GmbH (Fieberbrunn, Austria) (represented by: M. Konzett, lawyer)

Re:

Action brought against the decision of the Fourth Board of Appeal of EUIPO of 3 July 2020 (Case R 2450/2019-4), relating to opposition proceedings between Gebro Holding and Cara Therapeutics.

Operative part of the judgment

The Court:

|  |  |
| --- | --- |
| 1. | Dismisses the action; |

|  |  |
| --- | --- |
| 2. | Orders Cara Therapeutic, Inc. to pay the costs. |

---

---

[Top](#document1)